Large US IDN Drug-Eluting Stents
Share
Share

Large U.S. IDN sourcing drug-eluting stents from multiple vendors, resulting in wide price variances by region. MD Buyline assembled four pricing models and recommended elimination of Paclitaxel stents to reduce adverse outcomes. Identified $15.8 million in savings.